Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene

Pharmacogenetics and Genomics

Volumn 19, Issue 9, 2009, Pages 730-733

  Hsiao, Dun Jen ^a   Wu, Lawrence Shih Hsin ^c   Huang, Shih Yi ^b   Lin, Eugene ^c  

^a Health Policy and Care Research Center   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c VITA GENOMICS INC   (Taiwan)

Author keywords

Body fat; Obesity; Sibutramine; Single nucleotide polymorphisms; Weight loss

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; PLACEBO; SIBUTRAMINE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BODY COMPOSITION; BODY FAT; DNA POLYMORPHISM; FEMALE; HETEROZYGOTE DETECTION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; APPETITE DEPRESSANTS; BODY MASS INDEX; CYCLOBUTANES; FEMALE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; MALE; MIDDLE AGED; OBESITY; PLACEBOS; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN; WEIGHT LOSS; YOUNG ADULT;

EID: 70249136845     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283307cf1     Document Type: Article

References (10)

1. Patel MR, Donahue M, Wilson PW, Califf RM. Clinical trial issues in weight-loss therapy. Am Heart J 2006; 151:633-642
2. Sharma B, Henderson DC. Sibutramine: current status as an anti-obesity drug and its future perspectives. Expert Opin Pharmacother 2008; 9:2161-2173
3. Hauner H, Meier M, Jöckel KH, Frey UH, Siffert W. Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism. Pharmacogenetics 2003; 13:453-459
4. Vazquez Roque MI, Camilleri M, Clark MM, Tepoel DA, Jensen MD, Graszer KM, et al. Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine. Clin Gastroenterol Hepatol 2007; 5:829-837
5. Grudell AB, Sweetser S, Camilleri M, Eckert DJ, Vazquez-Roque MI, Carlson PJ, et al. A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Gastroenterology 2008; 135:1142-1154
6. Hamm HE. The many faces of G protein signaling. J Biol Chem 1998; 273:669-672
7. Siffert W. G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu Rev Med 2005; 56:17-28
8. Danoviz ME, Pereira AC, Mill JG, Krieger JE. Hypertension, obesity and GNB 3 gene variants. Clin Exp Pharmacol Physiol 2006; 33:248-252
9. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27:1182-1186
10. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998; 18:45-48